Form 4: Pfizer Director Suzanne Nora Johnson Acquires Phantom Stock Units

Director Suzanne Nora Johnson acquired 8,999 phantom stock units of Pfizer Inc. as part of deferred compensation.

Summary

• On April 24, 2025, Suzanne Nora Johnson, a director of Pfizer Inc., acquired 8,999 phantom stock units.
• The acquisition was made pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
• Each unit represents one phantom share of Pfizer's common stock.
• These units, priced at $22.78 each, represent deferred director's compensation that will be settled in cash or common stock upon Johnson's retirement from the Board of Directors.
• Following the transaction, Johnson beneficially owns 109,295.988 phantom stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a standard director compensation practice, aligning interests with shareholders. There are no indications of negative implications.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of Pfizer.
• The deferred compensation plan can be seen as a positive incentive for board members.

Future Outlook

The phantom stock units will be settled in cash or common stock at the director's election following retirement from the Board of Directors.

Industry Context

Directors receiving stock-based compensation is a common practice in the pharmaceutical industry to align their interests with shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• Companies like Johnson & Johnson (JNJ) and Merck (MRK) also utilize deferred compensation plans for their non-employee directors, often involving stock options or restricted stock units.
• The specific terms and amounts of these plans vary based on company size, performance, and governance practices.
• The use of phantom stock units is a fairly standard method of providing deferred compensation, offering similar benefits to restricted stock units without the immediate dilution of existing shares.

Stakeholder Impact

• The acquisition of phantom stock units by a director can positively influence shareholder confidence by aligning management's interests with the company's long-term success.

Key Dates

Keywords

Form 4, Pfizer, Director, Suzanne Nora Johnson, Phantom Stock Units, Deferred Compensation, Beneficial Ownership, PFE